Dve malo znamé stavby Jacquese Groaga v Olomouci (Deux édifices peu connus, dus à Jacques Groag, à Olomouc)ZATLOUKAL, P.Vlastivedny Vestnik moravsky. 1986, Vol 38, Num 2, pp 192-195Article

Neznamé dilo Jana Kotery v Luhacovicich (Une oeuvre inconnue de Jan Kotera à Luhacovice)ZATLOUKAL, P.Vlastivedny Vestnik moravsky. 1986, Vol 38, Num 3, pp 300-302Article

Pocatky moderni architektury na Morave a ve Slezsku. (Les débuts de l'architecture moderne en Moravie et en Silésie)ZATLOUKAL, P.Umeni Praha. 1984, Vol 32, Num 2, pp 140-154Article

Architektura lazni Velké Losiny. (L'architecture des bains de Velké Losiny)ZATLOUKAL, P.Vlastivedny Vestnik Moravsky Brno. 1983, Vol 35, Num 1, pp 68-75Article

Prehled architektury historismu 19. stoleti na Moravé. L'historisme dans l'architecture morave du 19 siècleZATLOUKAL, P.Umeni Praha. 1980, Vol 28, Num 4, pp 355-367Article

Gemcitabine in non-small cell lung cancer (NSCLC)MANEGOLD, C; ZATLOUKAL, P; KREJCY, K et al.Investigational new drugs. 2000, Vol 18, Num 1, pp 29-42, issn 0167-6997Article

Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer : A randomized phase II trial and the EORTC lung cancer cooperative groupMANGEGOLD, C; DRINGS, P; DOLENSKY, J et al.Annals of oncology. 1996, Vol 7, Num 6, pp 637-639, issn 0923-7534Article

A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancerMANEGOLD, C; ZANDWIJK, N. Van; BENNER, R. J et al.Annals of oncology. 2012, Vol 23, Num 1, pp 72-77, issn 0923-7534, 6 p.Article

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancerTAN, E. H; ROLSKI, J; ABRATT, R et al.Annals of oncology. 2009, Vol 20, Num 7, pp 1249-1256, issn 0923-7534, 8 p.Article

Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II studyO'BRIEN, M. E. R; SZCZESNA, A; KARNICKA, H et al.Annals of oncology. 2004, Vol 15, Num 6, pp 921-927, issn 0923-7534, 7 p.Article

A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive diseaseZATLOUKAL, P; CARDENAL, F; SZCZESNA, A et al.Annals of oncology. 2010, Vol 21, Num 9, pp 1810-1816, issn 0923-7534, 7 p.Article

Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)RECK, M; VON PAWEL, J; MANEGOLD, C et al.Annals of oncology. 2010, Vol 21, Num 9, pp 1804-1809, issn 0923-7534, 6 p.Article

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancerCULLEN, M. H; ZATLOUKAL, P; SÖRENSON, S et al.Annals of oncology. 2008, Vol 19, Num 5, pp 939-945, issn 0923-7534, 7 p.Article

Disseminated Nocardia asteroides infection in an immunocompetent woman following an arm injuryBENES, J; VIECHOVA, J; PICHA, D et al.Infection. 2003, Vol 31, Num 2, pp 112-114, issn 0300-8126, 3 p.Article

Waldenström's macroglobulinemia with pulmonary amyloidosisZATLOUKAL, P; BEZDICEK, P; SCHIMONOVA, M et al.Respiration (Basel). 1998, Vol 65, Num 5, pp 414-416, issn 0025-7931Article